Category Archives: Regeneron

USRetina Updates from Regeneron

REGENERON EXTENDS EYLEA® (aflibercept) INJECTION PAYMENT TERMS

Regeneron determined that they will be extending payment terms on purchases of Eylea® (aflibercept) to 150 days on all eligible invoices starting March 1, 2020.

Members should look for additional details and specifics from our pharmaceutical distribution partner, McKesson Specialty.

USRetina would like to recognize and thank Regeneron for this action and their continued responsiveness during this challenging time.

Continue reading